下腔静脉变异度联合中心静脉-动脉血二氧化碳分压差指导脓毒性休克液体复苏的疗效分析
该研究纳入江西省人民医院重症医学科2018年1月1日至2020年12月31日收治的80例脓毒性休克患者,按随机数字表法分为对照组和观察组各40例。对照组严格按EGDT策略复苏,目标为CVP 12-15 cmH2O、MAP>65 mmHg、UO>0.5 mL×kg-1×h-1、ScvO2>0.70;观察组以床旁超声动态监测的IVCV和Pcv-aCO2评估复苏终点,目标为下腔静脉固定充盈直径>2 cm、IVCV<18%、Pcv-aCO2<6 mmHg。结果显示观察组6小时MAP、ScvO2及6小时乳酸清除率更高,6小时和24小时复苏总量更少,机械通气时间更短,急性肺水肿发生率更低(2.5% vs. 20.0%,P<0.05);两组ICU住院时间、28天病死率及急性肾衰竭发生率无显著差异。
要点
- 观察组以床旁超声测下腔静脉固定充盈直径>2 cm、IVCV<18%、Pcv-aCO2<6 mmHg为复苏终点,6小时MAP 69.09±4.64 mmHg vs. 对照组66.37±4.32 mmHg(P<0.05)。
- 观察组6小时乳酸清除率55.64±6.23% vs. 对照组52.45±4.52%(P<0.05),6小时复苏总量2860.73±658.32 mL vs. 3568.54±856.43 mL(P<0.05)。
- 观察组机械通气时间6.78±3.45天 vs. 对照组8.45±2.85天(P<0.05),急性肺水肿发生率2.5%(1/40)vs. 20.0%(8/40)(P<0.05)。
- 两组ICU住院时间、28天病死率及急性肾衰竭发生率无显著差异。
- 对照组按EGDT复苏,目标为CVP 12-15 cmH2O、MAP>65 mmHg、UO>0.5 mL×kg-1×h-1、ScvO2>0.70。
适用人群与场景
- 江西省人民医院重症医学科2018年1月1日至2020年12月31日收治的脓毒性休克患者,共80例,对照组40例、观察组40例。
诊断标准与关键阈值
- 观察组复苏终点:床旁超声动态监测下腔静脉固定充盈直径>2 cm、IVCV<18%、Pcv-aCO2<6 mmHg。
- 对照组复苏目标:CVP 12-15 cmH2O(1 cmH2O≈0.098 kPa)、MAP>65 mmHg(1 mmHg≈0.133 kPa)、UO>0.5 mL×kg-1×h-1、ScvO2>0.70。
处置流程与药物剂量
- 两组均按脓毒性休克液体复苏指南进行液体复苏。
- 对照组严格按EGDT策略复苏,目标为CVP 12-15 cmH2O、MAP>65 mmHg、UO>0.5 mL×kg-1×h-1、ScvO2>0.70。
- 观察组以床旁超声动态监测的IVCV联合Pcv-aCO2评估复苏终点,目标为下腔静脉固定充盈直径>2 cm、IVCV<18%、Pcv-aCO2<6 mmHg。
研究设计与关键结果
- 研究类型为随机对照研究,纳入80例脓毒性休克患者,对照组40例、观察组40例。
- 两组复苏6小时和24小时的MAP、CVP、ScvO2均较复苏前显著升高,Pcv-aCO2和Lac显著下降,UO随复苏时间延长逐渐增加。
- 观察组复苏6小时和24小时IVCV较复苏前显著下降[(17.54±4.52)%、(18.32±3.64)% vs. (27.49±10.56)%,均P<0.05]。
- 观察组6小时MAP 69.09±4.64 mmHg vs. 对照组66.37±4.32 mmHg、ScvO2 0.666±0.033 vs. 0.645±0.035,均P<0.05;24小时MAP 75.16±3.28 mmHg vs. 70.12±2.18 mmHg,P<0.05;24小时CVP 9.25±1.49 cmH2O vs. 10.25±1.05 cmH2O,P<0.05。
- 观察组6小时乳酸清除率55.64±6.23% vs. 对照组52.45±4.52%,P<0.05;6小时复苏总量2860.73±658.32 mL vs. 3568.54±856.43 mL、24小时复苏总量4768.65±1085.65 mL vs. 5385.34±1354.83 mL,均P<0.05。
- 观察组机械通气时间6.78±3.45天 vs. 对照组8.45±2.85天,P<0.05;急性肺水肿发生率2.5%(1/40)vs. 20.0%(8/40),P<0.05。
- 两组ICU住院时间、28天病死率及急性肾衰竭发生率无显著差异。
证据类型、等级与局限
- 证据类型:随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,动态监测IVCV和Pcv-aCO2可有效指导脓毒性休克患者的早期液体复苏,与EGDT相比可显著缩短机械通气时间、减少复苏液量并降低急性肺水肿发生率,结合其无创特点具有一定临床优势。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of inferior vena cava variability (IVCV) combined with difference of central venous-to-arterial partial pressure of carbon dioxide (Pcv-aCO2) on guiding fluid resuscitation in septic shock.
METHODS: Patients with septic shock admitted to the department of critical care medicine of Jiangxi Provincial People's Hospital from January 1, 2018 to December 31, 2020 were enrolled, and they were divided into control group and observation group according to random number table method. Patients in both groups were given fluid resuscitation according to septic shock fluid resuscitation guidelines. The patients in the control group received fluid resuscitation strictly according to the early goal-directed therapy (EGDT) strategy. Resuscitation target: central venous pressure (CVP) 12-15 cmH2O (1 cmH2O≈0.098 kPa), mean arterial pressure (MAP) > 65 mmHg (1 mmHg≈0.133 kPa), mean urine volume (UO) > 0.5 mL×kg-1×h-1, central venous oxygen saturation (ScvO2) > 0.70. In the observation group, the endpoint of resuscitation was evaluated by IVCV dynamically monitored by bedside ultrasound and Pcv-aCO2. Resuscitation target: fixed filling of inferior vena cava with diameter > 2 cm, IVCV < 18%, and Pcv-aCO2 < 6 mmHg. The changes in recovery indexes before and 6 hours and 24 hours of resuscitation of the two groups were recorded, and the 6-hour efficiency of fluid resuscitation, 6-hour lactate clearance rate (LCR) and 6-hour and 24-hour total volume of resuscitation were also recorded; at the same time, the duration of mechanical ventilation, length of intensive care unit (ICU) stay, 28-day mortality and the incidence of acute renal failure and acute pulmonary edema between the two groups were compared.
RESULTS: A total of 80 patients were enrolled in the analysis, with 40 in the control group and 40 in the observation group. The MAP, CVP and ScvO2 at 6 hours and 24 hours of resuscitation in the two groups were significantly higher than those before resuscitation, while Pcv-aCO2 and blood lactic acid (Lac) were significantly decreased, and UO was increased gradually with the extension of resuscitation time, indicating that both resuscitation endpoint evaluation schemes could alleviate the shock state of patients. Compared with before resuscitation, IVCV at 6 hours and 24 hours of resuscitation in the observation group were decreased significantly [(17.54±4.52)%, (18.32±3.64)% vs. (27.49±10.56)%, both P < 0.05]. Compared with the control group, MAP and ScvO2 at 6 hours of resuscitation in the observation group were significantly increased [MAP (mmHg): 69.09±4.64 vs. 66.37±4.32, ScvO2: 0.666±0.033 vs. 0.645±0.035, both P < 0.05], 24-hour MAP was increased significantly (mmHg: 75.16±3.28 vs. 70.12±2.18, P < 0.05), but CVP was relatively lowered (cmH2O: 9.25±1.49 vs. 10.25±1.05, P < 0.05), indicating that the fluid resuscitation efficiency was higher in the observation group. Compared with the control group, 6-hour LCR in the observation group was significantly increased [(55.64±6.23)% vs. (52.45±4.52)%, P < 0.05], 6-hour and 24-hour total volume of resuscitation was significantly decreased (mL: 2 860.73±658.32 vs. 3 568.54±856.43, 4 768.65±1 085.65 vs. 5 385.34±1 354.83, both P < 0.05), the duration of mechanical ventilation was significantly shortened (days: 6.78±3.45 vs. 8.45±2.85, P < 0.05), while the incidence of acute pulmonary edema was significantly decreased [2.5% (1/40) vs. 20.0% (8/40), P < 0.05]. There was no significant difference in the length of ICU stay, 28-day mortality or incidence of acute renal failure between the two groups.
CONCLUSIONS: Dynamic monitoring of IVCV and Pcv-aCO2 can effectively guide the early fluid resuscitation of patients with septic shock, and compared with EGDT, it can significantly shorten the duration of mechanical ventilation, reduce the amount of fluid resuscitation, and reduce the incidence of acute pulmonary edema. Combined with its non-invasive characteristics, it has certain clinical advantages.
参考来源
- He Z, Yang X, Yang C, et al. [Efficacy analysis of inferior vena cava variability combined with difference of central venous-to-arterial partial pressure of carbon dioxide on guiding fluid resuscitation in patients with septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35307055. doi:10.3760/cma.j.cn121430-20210621-00918
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。